These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31364648)

  • 21. Efficacy of Shoushen granule on adenosine triphosphate binding cassette transporter A1, proprotein convertase subtilisin/kexin type 9 and toll-like receptor 4/nuclear factor kappa-B signaling pathway in ApoE-knockout mice.
    Li S; Cao H; Shen D; Chen C; Xing S; Dou F; Jia Q
    J Tradit Chin Med; 2019 Aug; 39(4):524-534. PubMed ID: 32186100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
    Wu N; Li RQ; Li L
    Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
    Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
    J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of Liver X Receptors and Peroxisome Proliferator-Activated Receptors by Lipid Extracts of Brown Seaweeds: A Potential Application in Alzheimer's Disease?
    Martens N; Zhan N; Voortman G; Leijten FPJ; van Rheenen C; van Leerdam S; Geng X; Huybrechts M; Liu H; Jonker JW; Kuipers F; Lütjohann D; Vanmierlo T; Mulder MT
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Quercetin on Atherosclerosis Based on Expressions of ABCA1, LXR-α and PCSK9 in ApoE
    Li SS; Cao H; Shen DZ; Chen C; Xing SL; Dou FF; Jia QL
    Chin J Integr Med; 2020 Feb; 26(2):114-121. PubMed ID: 31144159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
    Kratzer A; Buchebner M; Pfeifer T; Becker TM; Uray G; Miyazaki M; Miyazaki-Anzai S; Ebner B; Chandak PG; Kadam RS; Calayir E; Rathke N; Ahammer H; Radovic B; Trauner M; Hoefler G; Kompella UB; Fauler G; Levi M; Levak-Frank S; Kostner GM; Kratky D
    J Lipid Res; 2009 Feb; 50(2):312-26. PubMed ID: 18812595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fucoidan improves serum lipid levels and atherosclerosis through hepatic SREBP-2-mediated regulation.
    Park J; Yeom M; Hahm DH
    J Pharmacol Sci; 2016 Jun; 131(2):84-92. PubMed ID: 27094367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiatherosclerotic effect of farnesoid X receptor.
    Mencarelli A; Renga B; Distrutti E; Fiorucci S
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crocin ameliorates atherosclerosis by promoting the reverse cholesterol transport and inhibiting the foam cell formation via regulating PPARγ/LXR-α.
    Zhang F; Liu P; He Z; Zhang L; He X; Liu F; Qi J
    Cell Cycle; 2022 Jan; 21(2):202-218. PubMed ID: 34978526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet.
    Song G; Liu J; Zhao Z; Yu Y; Tian H; Yao S; Li G; Qin S
    Lipids Health Dis; 2011 Jan; 10():8. PubMed ID: 21241519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leonurine Prevents Atherosclerosis Via Promoting the Expression of ABCA1 and ABCG1 in a Pparγ/Lxrα Signaling Pathway-Dependent Manner.
    Jiang T; Ren K; Chen Q; Li H; Yao R; Hu H; Lv YC; Zhao GJ
    Cell Physiol Biochem; 2017; 43(4):1703-1717. PubMed ID: 29045950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism.
    Zhou X; He W; Huang Z; Gotto AM; Hajjar DP; Han J
    J Biol Chem; 2008 Jan; 283(4):2129-38. PubMed ID: 18029360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chitosan Oligosaccharides Attenuate Atherosclerosis and Decrease Non-HDL in ApoE-/- Mice.
    Yu Y; Luo T; Liu S; Song G; Han J; Wang Y; Yao S; Feng L; Qin S
    J Atheroscler Thromb; 2015; 22(9):926-41. PubMed ID: 25843117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PLK1 promotes cholesterol efflux and alleviates atherosclerosis by up-regulating ABCA1 and ABCG1 expression via the AMPK/PPARγ/LXRα pathway.
    Hu HJ; Wang XH; Zhang TQ; Liu Y; Chen ZR; Zhang ZZ; Huang H; Tang HF; Jiang ZS
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Dec; 1867(12):159221. PubMed ID: 35981705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transgenic expression of CYP7A1 in LDL receptor-deficient mice blocks diet-induced hypercholesterolemia.
    Ratliff EP; Gutierrez A; Davis RA
    J Lipid Res; 2006 Jul; 47(7):1513-20. PubMed ID: 16609145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-atherosclerosis and hyperlipidemia effects of herbal mixture, Artemisia iwayomogi Kitamura and Curcuma longa Linne, in apolipoprotein E-deficient mice.
    Shin HS; Han JM; Kim HG; Choi MK; Son CG; Yoo HR; Jo HK; Seol IC
    J Ethnopharmacol; 2014 Apr; 153(1):142-50. PubMed ID: 24508858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QiShenYiQi pill inhibits atherosclerosis by promoting TTC39B-LXR mediated reverse cholesterol transport in liver.
    Wang TT; Yang CY; Peng L; Li L; Chen NT; Feng X; Xie J; Wu TC; Xu T; Chen YZ
    Phytomedicine; 2024 Jan; 123():155192. PubMed ID: 37951148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moxibustion at CV4 alleviates atherosclerotic lesions through activation of the LXRα/ABCA1 pathway in apolipoprotein-E-deficient mice.
    Cui Y; Liu J; Huang C; Zhao B
    Acupunct Med; 2019 Aug; 37(4):237-243. PubMed ID: 31140825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Sberna AL; Assem M; Xiao R; Ayers S; Gautier T; Guiu B; Deckert V; Chevriaux A; Grober J; Le Guern N; Pais de Barros JP; Moore DD; Lagrost L; Masson D
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2232-9. PubMed ID: 21778422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE.
    Ason B; van der Hoorn JW; Chan J; Lee E; Pieterman EJ; Nguyen KK; Di M; Shetterly S; Tang J; Yeh WC; Schwarz M; Jukema JW; Scott R; Wasserman SM; Princen HM; Jackson S
    J Lipid Res; 2014 Nov; 55(11):2370-9. PubMed ID: 25258384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.